Role of 18 F-FDG PET in Assessment of Response in Non–Small Cell Lung Cancer
2009; Society of Nuclear Medicine and Molecular Imaging; Volume: 50; Issue: Suppl 1 Linguagem: Inglês
10.2967/jnumed.108.057216
ISSN1535-5667
Autores Tópico(s)Radiomics and Machine Learning in Medical Imaging
ResumoDespite recognized limitations, structural imaging with CT remains the standard technique for evaluating the response of lung cancer to both chemotherapy and radiotherapy. This evaluation has become increasingly important with the advent of neoadjuvant therapy before surgery. The high uptake of 18 F-FDG in most lung cancers and the demonstration that successful treatment reduces uptake have led to increasing enthusiasm for the use of PET and PET/CT to assess the therapeutic response. In this review, theoretic considerations and current evidence supporting the role of 18 F-FDG PET are discussed.
Referência(s)